Extensions for Using Data Elements from FHIR R5 in FHIR R4
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR R4
0.1.0 - STU
Extensions for Using Data Elements from FHIR R5 in FHIR R4 - Downloaded Version null See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R5-v3-VaccineType-for-R4 | Version: 0.1.0 | |||
| Standards status: Trial-use | Maturity Level: 0 | Computable Name: R5V3VaccineTypeForR4 | ||
This cross-version ValueSet represents content from http://terminology.hl7.org/ValueSet/v3-VaccineType|2.0.0 for use in FHIR R4.
This value set is part of the cross-version definitions generated to enable use of the
value set http://terminology.hl7.org/ValueSet/v3-VaccineType|2.0.0 as defined in FHIR R5
in FHIR R4.
The source value set is bound to the following FHIR R5 elements:
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
FHIR ValueSet http://terminology.hl7.org/ValueSet/v3-VaccineType|2.0.0, defined in FHIR R5 does not have any mapping to FHIR R4
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v3-VaccineType version 📍2.1.0| Code | Display |
| 1 | DTP |
| 10 | IPV |
| 100 | pneumococcal conjugate |
| 101 | typhoid, ViCPs |
| 11 | pertussis |
| 12 | diphtheria antitoxin |
| 13 | TIG |
| 14 | IG, NOS |
| 15 | influenza, split (incl. purified surface antigen) |
| 16 | influenza, whole |
| 17 | Hib, NOS |
| 18 | rabies, intramuscular injection |
| 19 | BCG |
| 2 | OPV |
| 20 | DTaP |
| 21 | varicella |
| 22 | DTP-Hib |
| 23 | plague |
| 24 | Anthrax |
| 25 | typhoid, oral |
| 26 | Cholera |
| 27 | botulinum antitoxin |
| 28 | DT (pediatric) |
| 29 | CMVIG |
| 3 | MMR |
| 30 | HBIG |
| 31 | Hep A, pediatric, NOS |
| 32 | meningococcal |
| 33 | pneumococcal |
| 34 | RIG |
| 35 | tetanus toxoid |
| 36 | VZIG |
| 37 | yellow fever |
| 38 | rubella/mumps |
| 39 | Japanese encephalitis |
| 4 | M/R |
| 40 | rabies, intradermal injection |
| 41 | typhoid, parenteral |
| 42 | Hep B, adolescent/high risk infant |
| 43 | Hep B, adult |
| 44 | Hep B, dialysis |
| 45 | Hep B, NOS |
| 46 | Hib (PRP-D) |
| 47 | Hib (HbOC) |
| 48 | Hib (PRP-T) |
| 49 | Hib (PRP-OMP) |
| 5 | measles |
| 50 | DTaPHib |
| 51 | Hib-Hep B |
| 52 | Hep A, adult |
| 53 | typhoid, parenteral, AKD (U.S. military) |
| 54 | adenovirus, type 4 |
| 55 | adenovirus, type 7 |
| 56 | dengue fever |
| 57 | Hantavirus |
| 58 | Hep C |
| 59 | Hep E |
| 6 | rubella |
| 60 | herpes simplex 2 |
| 61 | HIV |
| 62 | HPV |
| 63 | Junin virus |
| 64 | leishmaniasis |
| 65 | leprosy |
| 66 | Lyme disease |
| 67 | malaria |
| 68 | melanoma |
| 69 | parainfluenza-3 |
| 7 | mumps |
| 70 | Q fever |
| 71 | RSV-IGIV |
| 72 | rheumatic fever |
| 73 | Rift Valley fever |
| 74 | rotavirus |
| 75 | smallpox |
| 76 | Staphylococcus bacterio lysate |
| 77 | tick-borne encephalitis |
| 78 | tularemia vaccine |
| 79 | vaccinia immune globulin |
| 8 | Hep B, adolescent or pediatric |
| 80 | VEE, live |
| 81 | VEE, inactivated |
| 82 | adenovirus, NOS |
| 83 | Hep A, ped/adol, 2 dose |
| 84 | Hep A, ped/adol, 3 dose |
| 85 | Hep A, NOS |
| 86 | IG |
| 87 | IGIV |
| 88 | influenza, NOS |
| 89 | polio, NOS |
| 9 | Td (adult) |
| 90 | rabies, NOS |
| 91 | typhoid, NOS |
| 92 | VEE, NOS |
| 93 | RSV-Mab |
| 94 | MMRV |
| 95 | TST-OT tine test |
| 96 | TST-PPD intradermal |
| 97 | TST-PPD tine test |
| 98 | TST, NOS |
This value set expansion contains 100 concepts.
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r5.r4#0.1.0 based on FHIR 4.0.1. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change